Abstract:Erythropoietin-producing hepatocellular carcinoma cell surface type-A receptor 3 (EPHA3) has been found to promote the proliferation and survival of prostate cancer (PCa) cell lines and prostate tumor development in nude mice. However, the regulation of EPHA3 in PCa remains largely unknown. This study is aimed to investigate the association between EPHA3 expression and androgen receptor (AR) signaling and the potential mechanism. We determined mRNA and protein levels of EPHA3 and AR signaling-related genes in the PCa cell line 22Rv1 by reverse transcription-polymerase chain reaction (RT-PCR) and western blotting, respectively. The EPHA3 mRNA and protein levels were both found to be elevated by dihydrotestosterone (DHT) hormone in a dose- and time-dependent manner, as AR and prostate-specific antigen (PSA) expression were increased. Similarly, EPHA3 protein levels were also increased in the PCa cell line LNCaP stimulated with DHT or mibolerone (Mib). Overexpression of pEGFP-AR in 22Rv1 cells significantly increased the EphA3 level, while AR knockdown with small interfering RNA (siRNA) for AR (siAR) markedly decreased the expression of EPHA3. The key EPHA3 promoter region associated with AR regulation was evaluated by co-transfection of various pGL3-basic-luciferase reporter plasmids, containing EPHA3 core promoter fragments differing in length, with the AR plasmid or siAR into 22Rv1 cells. AR overexpression in 22Rvl cells raised the EphA3 promoter transcription activity of pGL3-EPHA3-Luc (EPHA3-Luc)-789, and vice versa. Similarly, luciferase activity of EPHA3-Luc-317 was also clearly affected. However, truncated EPHA3-Luc-237 without the transcription factor specific protein 1 (SP1) binding sites or EPHA3-Luc-789SP1 with modified SP1 binding sites clearly decreased EPHA3 promoter activity regardless of whether AR was overexpressed or blocked. Treatment of 22Rv1 cells with 10 and 100 nM of the SP1 inhibitor mithramycin A for 24 and 48 h significantly reduced EPHA3 mRNA and protein levels. Additionally, selective inhibition of SP1 with siRNA SP1 (siSP1) at various concentration from 25 to 75 nM, reduced the EPHA3 protein level in PCa LNCaP cells, accordingly. Co-immunoprecipitation (co-IP) and chromatin IP (ChIP) assays were performed to determine whether AR forms a transcription factor complex with Sp1 that binds the EPHA3 core promoter region to sense androgen induction. The result suggests that the interaction of AR and SP1 contributes to regulate EPHA3 expression, and the SP1 binding sites (-295 similar to-261) in the EPHA3 core promoter region is crucial to the regulation of EPHA3 expression in response to androgen hormone stimuli.

EphA1 expression and prostate cancer

Eukaryotic Translation Initiation Factor 5A2 is Highly Expressed in Prostate Cancer and Predicts Poor Prognosis.

Detection of aberrant methylation of RARβ2, GSTP1 and DAPK gene in prostate cancer and its clinical significance

Increased Expression of EphA1 Protein in Prostate Cancers Correlates with High Gleason Score.

Downregulation of EphA5 by Promoter Methylation in Human Prostate Cancer

Expression of EphA1 Gene in colorectal Cancers and Its Clinical Significance

Aberrant Methylation Of Epha7 In Human Prostate Cancer And Its Relation To Clinicopathologic Features

Differentail expression of EphB1 mRNA and protein in colorectal cancer and its clinicopathologic significance

Diagnostic and Prognostic Value of Tissue and Circulating Levels of Ephrin-A2 in Prostate Cancer

The Prognosis Value of EphA3 and the Androgen Receptor in Prostate Cancer Treated with Radical Prostatectomy.

Androgen Receptor Up-Regulates EphA3 Expression in Androgen-Dependent Prostate Cancer Cell Lines

Expression of receptor tyrosine kinase EphA1 mRNA in bladder cancer and its clinical significance

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Androgen Receptor Induces EPHA3 Expression by Interacting with Transcription Factor SP1

Expression of EphB4 in prostate cancer tissue and its clinical significance in tumor lymphangiogenesis and metastasis

EphA6 Promotes Angiogenesis and Prostate Cancer Metastasis and is Associated with Human Prostate Cancer Progression.

Expression of Eag1 K(+) Channel in Prostate Cancer and Its Significance

Ligand-dependent EphA7 Signaling Inhibits Prostate Tumor Growth and Progression

The relationship between the expression of EphA1 in gastric carcinoma, metastasis and survival

EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells.

Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis.